How Can Stem Cells Treat
Neurological Disorders?
Neurological Disorders
Whether you’ve sustained an injury to the brain or spine, or suffer from a neurological or neurogenerative disease, symptoms can be difficult to treat. Those symptoms can fluctuate from mild to severe—including poor memory, numbness, weakness, sensory disturbances, poor mobility, loss of vision, slurred speech, and cognitive decline—that turn even routine tasks into major challenges.
While standard treatment options such as surgery and medications may be available, surgery can be complex and risky, while medications may cause serious side effects.
Conditions We Treat:
-
Stroke
-
Spinal cord injury (SCI)
-
Multiple sclerosis (MS)
-
Peripheral neuropathy
-
Cerebral palsy
-
Autism (Autistic Spectrum Disorder)
-
Brain injuries such as TBI and CTE
-
And other disorders
Advanced Treatment Options are Available
Discover how stem cell therapy has helped many patients who once lost hope for relief from symptoms but now enjoy more active lives with less pain and more energy.
Citations and Scientific References
Our medical team takes pride in our reputation for collaborating with other scientists worldwide on research studies and of established scientific publications. Review these published studies that support the science of our treatment protocols.
Citations
VIEW CITATIONS
-
Földes, A., Kádár, K., Kerémi, B., Zsembery, Á., Gyires, K., S Zádori, Z., & Varga, G. (2016). Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage. Current neuropharmacology, 14(8), 914–934. https://www.eurekaselect.com/article/73157
-
Zheng H, Zhang B, Chhatbar PY, Dong Y, Alawieh A, Lowe F, Hu X, Feng W. Mesenchymal Stem Cell Therapy in Stroke: A Systematic Review of Literature in Pre-Clinical and Clinical Research. Cell Transplant. 2018 Dec;27(12):1723-1730. https://pubmed.ncbi.nlm.nih.gov/30343609/.
-
Schepici G, Silvestro S, Bramanti P, Mazzon E. Traumatic Brain Injury and Stem Cells: An Overview of Clinical Trials, the Current Treatments and Future Therapeutic Approaches. Medicina (Kaunas). 2020 Mar 19;56(3):137. https://pubmed.ncbi.nlm.nih.gov/32204311/.
-
Rahman MM, Islam MR, Islam MT, Harun-Or-Rashid M, Islam M, Abdullah S, et al. Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives. Biology. 2022; 11(1):147. https://doi.org/10.3390/biology11010147
-
Kassis I, Petrou P, Vaknin-Dembinsky A, Karussis D. Mesenchymal stem cells in neurological diseases. Clin. Invest. https://pmc.ncbi.nlm.nih.gov/articles/PMC8024997/.
-
Chung JW, Chang WH, Bang OY, Moon GJ, Kim SJ, Kim SK, Lee JS, Sohn SI, Kim YH; STARTING-2 Collaborators. Efficacy and Safety of Intravenous Mesenchymal Stem Cells for Ischemic Stroke. Neurology. 2021 Feb 16;96(7):e1012-e1023. Available from: https://doi.org/10.1212/WNL.0000000000011440
-
Sun, J. M., Dawson, G., Franz, L., Howard, J., McLaughlin, C., Kistler, B., Waters-Pick, B., Meadows, N., Troy, J., & Kurtzberg, J. Infusion of human umbilical cord tissue mesenchymal stromal cells in children with autism spectrum disorder. Stem cells translational medicine.2020:9(10):1137–1146. Available from: https://doi.org/10.1002/sctm.19-0434
-
